Evidence map›Paper›PMID 42627381›Full record

ArticleWorld journal of urology2026

The impact of intraoperative ureteral stent omission on postoperative complications during radical cystectomy.

John Pfail, Connor O'Leary, Melinda Fu, Alain Kaldany, Kevin Chua, Rachel Passarelli, Benjamin Lichtbroun, Hiren Patel, Arnav Srivastava, David Golombos and 3 more

Abstract read
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

John PfailSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. jp2009@rwjms.rutgers.edu.
Connor O'LearySection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Melinda FuSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Alain KaldanySection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Kevin ChuaSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Rachel PassarelliSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Benjamin LichtbrounSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Hiren PatelDepartment of Urology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Arnav SrivastavaDivision of Urologic Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
David GolombosSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Thomas L JangSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Vignesh T PackiamSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Saum GhodoussipourSection of Urologic Oncology, Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
NCI NIH HHS P30 CA072720NCI NIH HHS P30CA072720
6 · The paper itself

Abstract

introductionUreteral stents are traditionally placed intraoperatively during radical cystectomy (RC) to optimize healing and avoid short and long-term complications. However, strong evidence supporting this practice is lacking. We aim to assess the impact of ureteral stent placement with postoperative complications following RC.

methodsThe National Surgical Quality Improvement Program database included 4,375 patients who underwent RC from 2019 to 2021. Baseline characteristics and complication rates were stratified by utilization of ureteral stenting. Primary endpoints included 30-day complications, length of stay (LOS), and readmissions. Multivariable analyses was performed to determine the association of no stent placement with postoperative morbidity.

resultsOf the 4,375 patients who underwent RC, 413 (9.4%) did not receive intraoperative stent placement. Patients without stent placement had lower ASA (ASA < 3: 21% v. 27%; p < 0.01), lower median BMI 27 v. 28; p < 0.01), and lower median operative times (292 min v. 322; p < 0.01). There was no difference in preoperative median estimated glomerular filtration rate (CKD-EPI creatine Eq. 2021) between patients with or without stents placed (70 mL/min/1.73m

conclusionsThe omission of ureteral stents in a select population of patients did not appear to increase the risk of morbidity including 30-day complications, postoperative renal failure, UTI, urine leak, or ureteral strictures, indicating stentless RC may be performed safely in select patients.

Indexed as

CystectomyIntraoperative CarePostoperative ComplicationsStentsUreterUrinary Bladder NeoplasmsAgedFemaleHumansLength of StayMaleMiddle AgedPatient ReadmissionRetrospective StudiesPostoperative complicationsRadical cystectomyUreteral stentUrologic oncology

Identifiers

PMID42627381
PMCPMC13498471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.